Stock

20 stories about Stock
ג'ינס ליוויס קמפיין פיקוח על נשק ארה"ב

Cannabis-Blockchain Company Proves Nothing is Out of Range with Gun Safety Holdings

29.10.18|Lilach Baumer
Israel-based Fantasy Network sold its fantasy sports division to employees in October 2017, essentially becoming a shelf company
נאסד"ק וול סטריט

Novartis-Backed Gamida Downgrades Nasdaq IPO Expectations to $50-$60 Million

18.10.18|Lilach Baumer
The Jerusalem-based biotech company filed for a $69 million initial public offering in September but disclosed no pricing terms
חנות פוקס fox

Israeli Retailer Fox Trends Up After Company-Hired Investigator Clears CEO of Sexual Harassment Allegations

15.10.18|Lilach Baumer
In August, Israel’s Channel Ten News aired a report detailing an alleged history of sexual misconduct by the company's CEO, director, and controlling shareholder Harel Wiesel
אסף אלימלך מנכ"ל Plus500

Playtech Offloads Stake in Trading Firm Plus500

09.09.18|Dror Reich
The online gambling company bought a 10% stake in London-listed Plus500 in 2015 as part of an attempt to acquire the then-struggling company
קאר שולץ מנכל טבע

Available Cash Prompts Teva to Make $400 Million Debt Tender Offer

05.09.18|Lilach Baumer
The drugmaker is offering to pay senior notes due 2019 and 2020 in cash
Thomas Cochrane10th Earl of Dundonald Portrait

In Market Manipulation Case, Israeli Supreme Court Ruling Goes Back to 1814

29.08.18|Lilach Baumer
On Wednesday, Israel's Supreme Court rejected the appeal submitted by Israeli businessman Nochi Dankner and upped his jail time from two years to three
וורן באפט אסיפת בעלי המניות מאי 2018

Berkshire Hathaway Builds Teva Position for Third Quarter in a Row

15.08.18|Lilach Baumer
In a Tuesday Filing, Warren Buffett’s holding company revealed it has increased its stake in Teva by 6.7% in the second quarter of 2018
נאסדק נאסד"ק ניו יורק בורסה בועה

Barclays Sees Potential Upside in Nice Stock Following Second-Quarter Reports

13.08.18|CTech
On Thursday, Israel-headquartered Nice reported GAAP revenues of $342 million, a 10% increase year-over-year, bolstered by a 28% year-over-year increase in cloud revenues
נאסד"ק וול סטריט

RedHill’s Clinical Trial Results Undermine Its Underwritten Offering

12.08.18|Dror Reich
The gastro treatment company announced a successful Crohn's disease treatment trial two weeks ago. While investors initially seemed hyped, successful trials from competitors brought RedHill’s stock down since
נאסדק נאסד"ק ניו יורק בורסה בועה

Surveillance Company Ability Looking to Raise Up to $50 Million in Shelf Offering

26.07.18|CTech
Earlier this month, the Tel Aviv-based company announced it has received a delisting determination from Nasdaq
נאסד"ק וול סטריט

Gastro Treatment Company RedHill Wants to Raise $117 on Nasdaq

24.07.18|Lilach Baumer
The Tel Aviv-headquartered company announced on Monday that Nasdaq approved its listing on its second tier, the Global Market. RedHill's ADSs were previously listed on Nasdaq Capital Market
נאסד"ק וול סטריט

Nasdaq Sends Notice of Delisting to Interception Company Ability

15.07.18|CTech
Last week, Tel Aviv-based Ability announced the SEC is considering disciplinary action against it in connection to a 2015 merger, and to business information filed by the company
בורסה בורסת תל אביב 6

Israeli Regulator Issues Warning About Two Algorithmic Trading Firms

13.07.18|Tomer Ganon
Emerald Base Ltd., which represents Trade Station Ltd. in Israel, and TradeStation Securities Inc. have not received regulatory approval from the Israel Securities Authority
ניר צוק מייסד ו סמנכל טכנולוגיות פאלו אלטו נטוורקס

Palo Alto Networks Looking to Raise $1.5 Billion in Bonds

10.07.18|CTech
Palo Alto reported revenues of $542.4 for the second quarter of 2018, a 28% year-over-year increase
נאסד"ק וול סטריט

Oral Insulin Capsule Developer Oramed Raises $18 Million in Direct Offering

10.07.18|CTech
Jerusalem-headquartered Oramed intends to use the recent proceeds for research and development and for clinical trials
זיו קופ משקיע הון סיכון

The Israeli One Billion Dollar Club—a Defining Moment for Israeli VCs

04.07.18|Ziv Kop
As mass amounts of capital are poured into Israeli startups, venture capitalist Ziv Kop outlines the challenges the local industry faces
בורסה בורסת תל אביב 5

Cancer Treatment Company BioCanCell Raises $22.9 Million in Private Placement

02.07.18|CTech
The company announced the issuance of 5.9 million new shares in April
רב סרן אסף שיש מטיס רחפן

CTech's Sunday Roundup of Israeli Tech News

01.07.18|CTech
The Israeli military has big plans for small drones. Volkswagen sees blockchain-enabled cars in Its future.
נאסד"ק וול סטריט

Fourth Time’s the Charm for Entera Bio IPO

01.07.18|Dror Reich
The Israel-based oral drug developer listed on Nasdaq on Thursday, pricing 1.4 million units of one share and one warrant at $8 each
קאר שולץ מנכל טבע

Goldman Sachs Sees 16% Upside in Teva Stock

26.06.18|Dror Reich
Following a meeting with Teva’s management, the bank's analysts reiterated their "buy" recommendation with a higher target price